Corrigendum to “PI3K Inhibition Augments the Therapeutic Efficacy of a 3a–aza-Cyclopenta[α]indene Derivative in Lung Cancer Cells [Translational Oncology 7 (2014) 256–266.e5]

• Kumar Sanjiv,
• Chi-Wei Chen,
• Rajesh Kakadiya,
• Satishkumar Tala,
• Sharda Suman,
• Ming-Hsi Wu,
• Yen-Hui Chen,
• Tsann-Long Su,
• Te-Chang Lee

Affiliations

Kumar Sanjiv

Molecular Medicine Program, Taiwan International Graduate Program, Academia Sinica, Taipei, Taiwan

Chi-Wei Chen

Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei, Taiwan

Rajesh Kakadiya

Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan

Satishkumar Tala

Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan

Sharda Suman

Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan

Ming-Hsi Wu

Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan

Yen-Hui Chen

Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan

Tsann-Long Su

Molecular Medicine Program, Taiwan International Graduate Program, Academia Sinica, Taipei, Taiwan

Te-Chang Lee

Molecular Medicine Program, Taiwan International Graduate Program, Academia Sinica, Taipei, Taiwan